Increase in Medical Expenses for FY 2024 in Japan Reaches an All-Time High of 48 Trillion Yen
Japan's Medical Costs Continue to Rise, According to Preliminary Data
Japan's medical costs have increased for the fourth consecutive year, reaching a record high of 48 trillion yen in fiscal year 2024, according to preliminary data presented by the health ministry on August 29.
The data, which covers payments from the public health insurance system, taxpayers' money, and out-of-pocket costs, suggests that the aging population and advances in medical technology are driving the increase in healthcare expenditures. The rise was 1.5% compared to the previous year.
However, it's important to note that the preliminary total does not include costs fully paid by patients and those covered by the worker compensation system. Additionally, expenses related to the COVID-19 pandemic nearly halved, amounting to approximately 240 billion yen.
The decline in COVID-19-related expenses may not necessarily affect the data's suggestion that the Japanese government may need to allocate more resources to healthcare in the future. The preliminary total of medical expenses, excluding COVID-19 costs, is indicative of the current state of medical costs in Japan.
The data covered by the preliminary report accounts for approximately 98% of the entire medical expenses in the country. The preliminary total, excluding COVID-19 costs, does not change the data's reflection of the current state of medical costs in Japan.
Despite the preliminary total not suggesting any immediate need for the Japanese government to allocate more resources to healthcare, the data does indicate that the ongoing need to fund healthcare amid demographic changes is the largest issue for the system. The increase in healthcare expenditures in 2024 is mainly due to the aging population, which leads to significantly higher healthcare costs; universal health coverage through public insurance contributes to high state-financed spending.
In conclusion, while the preliminary data shows a continuation of the trend of increasing medical costs in Japan, it also highlights the challenges that the Japanese government faces in funding healthcare in the future. The data presented reflects the current state of medical costs in Japan, but the government may need to consider additional funding to meet the needs of an aging population and the ongoing advances in medical technology.
